The Wayback Machine - https://web.archive.org/web/20111129012458/http://en.wikipedia.org/wiki/Ebrotidine

Ebrotidine

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Ebrotidine
Systematic (IUPAC) name
N-(4-bromophenyl)sulfonyl-N'-[2-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]ethyl]methanimidamide
Clinical data
Pregnancy cat.  ?
Legal status  ?
Routes Oral
Identifiers
CAS number 100981-43-9
ATC code  ?
PubChem CID 65869
UNII TMZ3IBW2OW YesY
Chemical data
Formula C14H17BrN6O2S3 
Mol. mass 477.42 g/mol
 YesY(what is this?)  (verify)

Ebrotidine is an H2 receptor antagonist with gastroprotective activity. It has a gastro-protective action against ethanol-, aspirin- or stress-induced gastric mucosal damage.[1] The antisecretory properties of ebrotidine are similar to those of ranitidine, and approximately 10-fold greater than those of cimetidine. Ebrotidine has anti-Helicobacter pylori activity via inhibition of the urease enzyme and the proteolytic and mucolytic activities of the bacterium. However, its activity is synergistic with a number of antibacterial agents. Ebrotidine counteracts the inhibitory effects of H. pylori lipo-polysaccharides.

Ebrotidine has been shown to be as effective as ranitidine for the treatment of gastric or duodenal ulcers or erosive reflux oesophagitis, with significantly better ulcer healing rates (albeit inexplicably) in those who smoke.[1]

[edit] References

  1. ^ a b Patel SS, Wilde MI (Jun 1996). "Ebrotidine". Drugs 51 (6): 974–980. PMID 8736619. 


Personal tools
Namespaces
Variants
Actions
Navigation
Interaction
Toolbox
Print/export
Morty Proxy This is a proxified and sanitized view of the page, visit original site.